Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5

摘要: Abstract Background European regional variation in cancer survival was reported the EUROCARE-4 study for patients diagnosed 1995–1999. Relative (RS) estimates are here updated with of oesophagus, stomach and small intestine from 2000 to 2007. Trends RS 1999–2001 2005–2007 presented monitor discuss improvements patient Europe. Materials methods EUROCARE-5 data 29 countries (87 registries) were used investigate 1- 5-year RS. Using registry-specific life-tables stratified by age, gender calendar year, age-standardised ‘complete analysis’ country region calculated Northern, Southern, Eastern Central Europe, Ireland United Kingdom (UK). Survival trends periods 1999–2001, 2002–2004 investigated using ‘period’ approach. We computed conditional on surviving first year (5-year survival), as ratio 1-year Results Oesophageal (40% 12%, respectively) remained poor Patient worst (8%), Northern (11%) Southern Europe (10%). Europe-wide, there a 3% improvement oesophageal 2005–2007, UK (3%), (4%) showing large improvements. 25%. (17%) (19%) had poorest survival. best (30%), though only an 2% 2005–2007. Small 48%, having (54%), (37%). Five-year 8% Central, greatest increases (⩾9%). Conclusions these sites, particularly cancer, remains wide variation. Further investigation into variation, including analysis histology anatomical sub-site, will yield insights better explain observed over time.